Literature DB >> 2657052

Cor pulmonale in cystic fibrosis.

M H Götz1, O C Burghuber, U Salzer-Muhar, W Wolosczuk, M Weissel, E Hartter.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2657052      PMCID: PMC1291916     

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  50 in total

1.  The use of digitalis in patients with pulmonary disease.

Authors:  L H Green; T W Smith
Journal:  Ann Intern Med       Date:  1977-10       Impact factor: 25.391

Review 2.  The cardiovascular system in cystic fibrosis.

Authors:  A J Moss
Journal:  Pediatrics       Date:  1982-11       Impact factor: 7.124

3.  Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients.

Authors:  P J Currie; J B Seward; K L Chan; D A Fyfe; D J Hagler; D D Mair; G S Reeder; R A Nishimura; A J Tajik
Journal:  J Am Coll Cardiol       Date:  1985-10       Impact factor: 24.094

4.  Effect of respiration on the echocardiogram in children with cystic fibrosis.

Authors:  D P Morin; C M Cottrill; G L Johnson; H D Wilson; D L Vine; J A Noonan
Journal:  Pediatrics       Date:  1980-01       Impact factor: 7.124

Review 5.  Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem.

Authors:  P D Henry
Journal:  Am J Cardiol       Date:  1980-12-01       Impact factor: 2.778

6.  Assessment of cor pulmonale in cystic fibrosis by echocardiography.

Authors:  E Ryssing
Journal:  Acta Paediatr Scand       Date:  1977-11

7.  Early effects of oxygen administration and prognosis in chronic obstructive pulmonary disease and cor pulmonale.

Authors:  K Ashutosh; G Mead; M Dunsky
Journal:  Am Rev Respir Dis       Date:  1983-04

8.  Cardiac function in patients with cystic fibrosis: evaluation by two-dimensional and Doppler echocardiography.

Authors:  I P Panidis; J F Ren; D S Holsclaw; M N Kotler; G S Mintz; J Ross
Journal:  J Am Coll Cardiol       Date:  1985-09       Impact factor: 24.094

9.  The effect of digoxin on exercise capacity and exercising cardiac function in cystic fibrosis.

Authors:  A L Coates; K Desmond; M I Asher; J Hortop; P H Beaudry
Journal:  Chest       Date:  1982-11       Impact factor: 9.410

10.  Inhibition of hypoxic pulmonary vasoconstriction by nifedipine.

Authors:  T Kennedy; W Summer
Journal:  Am J Cardiol       Date:  1982-10       Impact factor: 2.778

View more
  2 in total

Review 1.  The heart in cystic fibrosis.

Authors:  Rowland J Bright-Thomas; A Kevin Webb
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

2.  Cystic Fibrosis Transmembrane Conductance Regulator Genotype, Not Circulating Catecholamines, Influences Cardiovascular Function in Patients with Cystic Fibrosis.

Authors:  Alexander L Bisch; Courtney M Wheatley; Sarah E Baker; Elizabeth R Peitzman; Erik H Van Iterson; Theresa A Laguna; Wayne J Morgan; Eric M Snyder
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2019-03-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.